Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France
Conditions: Chronic Myeloid Leukemia Interventions: Other: Asciminib Sponsors: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
Ibd CAncer and seRious Infections in France (I-CARE 2)
Conditions: IBD; Ulcerative Colitis; Crohn Disease Interventions: Other: Non-interventional Sponsors: Groupe d ' Etude Therapeutique des Affections Inflammatoires Digestives; Sanoia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Building of a Diagnostic/Prognostic Database for Human ERG Variant Effects
Conditions: Long QT Syndrome Sponsors: Nantes University Hospital; Institut National de la Sant é Et de la Recherche Médicale, France; Centre National de la Recherche Scientifique, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
Analysis of Suicide Dynamics in Link to the COVID-19 Pandemic
Conditions: COVID-19 Sponsors: University Hospital, Strasbourg, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting
Conditions: Desmoid Tumor Interventions: Procedure: Cryoablation; Drug: Chemotherapy drug Sponsors: University Hospital, Strasbourg, France; Direction G énérale de l ' Offre des Soins (DGOS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Olfactory Cleft Stenosis and Obstruction on Paranasal Sinus CT Scan in Pre Septo Rhinoplasty Patients Without Respiratory Mucosa Pathology : Normal Variants or Pathologic Findings ?
Conditions: Olfactory Impairment Sponsors: Central Hospital, Nancy, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Towards a Food Ingredient Clinically Proven to Benefit Gut Health: Novel RG-I Variants
Conditions: Healthy Interventions: Dietary Supplement: Maltodextrin; Dietary Supplement: Chicory RG-I; Dietary Supplement: Carrot RG-I Sponsors: Örebro University, Sweden; NutriLeads B.V. (Wageningen, The Netherlands); ProDigest (Ghent, Belgium); Ambiotis (Toulouse, France) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease
Conditions: Parkinson Disease Interventions: Other: Continuous subcutaneous apomorphine infusion (CSAI) Sponsors: University Hospital, Toulouse; ELIVIE France; EVER Pharma France SAS; NHC SAS, France; Orkyn ' ; ETPARK Association, Toulouse, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
Risk Markers of Arterial Aging. The Paris Prospective Study III-2
Conditions: Arterial Stiffness Interventions: Other: high-precision carotid echo-tracking Sponsors: Institut National de la Sant é Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
Prevalence and Risk Factors of Anxiety and Depression During the Health Crisis Linked to COVID-19
Conditions: COVID-19; COVID-19 Anxiety and Depression Syndromes Sponsors: University Hospital, Strasbourg, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials
Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC
Conditions: Triple-negative Breast Cancer Interventions: Drug: Pembrolizumab 25 mg/ml; Drug: Paclitaxel injection Sponsors: UNICANCER; MSD France; Vall d ' Hebron Institute of Oncology; SOLTI Breast Cancer Research Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials
Prevalence and Risk Factors of Anxiety and Depression Among Policemen During the Health Crisis Linked to COVID-19
Conditions: COVID-19; Anxiety Syndrome; Depression Syndrome; Policemen Sponsors: University Hospital, Strasbourg, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials
Management of Drug-resistant Epilepsy in Infants and Children: a Real-life Study of the Use of the Ketogenic Diet in France and the KetoCal ® Range in Its Maintenance
Conditions: Drug Resistant Epilepsy; Ketogenic Dieting Interventions: Other: Ketocal Sponsors: Nutricia Nutrition Clinique; Euraxi Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
The Determinants of Fertility Preservation in TRANSgender Patients.
Conditions: Fertility Preservation; Transgender; Transgenderism Interventions: Behavioral: No intervention. Sponsors: Central Hospital, Nancy, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
Holistic Mixed Approaches to Capture the Real Life of Children With Rare Eye Diseases
Conditions: Eye Diseases; Severe Loss of Vision; Blindness; Quality of Life Interventions: Other: Mixed Methods Research (MMR) using quantitative (QUAN) and qualitative (QUAL) tools Sponsors: University Hospital, Strasbourg, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2023 Category: Research Source Type: clinical trials
